Strides Shasun's API site at Puducherry gets 'zero 483’ status

08 May 2017 Evaluate

Strides Shasun's active pharmaceutical ingredients (API) manufacturing site in Puducherry was recently inspected by the United States Food and Drug Administration (US FDA) and the approval was renewed with 'Zero 483' status. Over the last month, three facilities were inspected by US FDA and cleared with Zero 483 Status.

The Company’s flagship Facility (KRSG Gardens) in Bangalore was also inspected and cleared by US FDA in June 2016 without any ‘Zero 483’ observations.  With this, the company's last four US FDA inspections were successfully completed without any observations.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.

Strides Pharma Scien Share Price

798.35 4.75 (0.60%)
28-Jan-2026 13:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1615.05
Dr. Reddys Lab 1223.50
Cipla 1315.00
Zydus Lifesciences 891.85
Lupin 2123.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×